Isabel Quintanilla

Isabel Quintanilla

Auto-generated profile, based on publicly available information

Isabel Quintanilla

High-Throughput Imaging Facility (HiTIF), Laboratory of Receptor Biology, Center for Cancer Research

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 February 2018 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
DWDarawalee Wangsa
Darawalee Wangsa
IQIsabel Quintanilla
Isabel Quintanilla
KTKeyvan Torabi
Keyvan Torabi
MVMaria Vila‐Casadesús
Maria Vila‐Casadesús
AEAmaia Ercilla
Amaia Ercilla
JCJordi Camps
Jordi Camps
A considerable proportion of tumors exhibit aneuploid karyotypes, likely resulting from the progressive loss of chromosomes after whole‐genome duplication. Here, by using isogenic diploid and near‐tetraploid (4N) single‐cell‐derived clones from the same parental cell lines, we aimed at exploring how polyploidization affects cellular functions and how tetraploidy generates chromosome instability. Gene expression profiling in 4N clones revealed a significant enrichment of transcripts involved in cell cycle and DNA replication. Increased levels of replication stress in 4N cells resulted in DNA damage, impaired proliferation caused by a cell cycle delay during S phase, and higher sensitivity to S phase checkpoint inhibitors. In fact, increased levels of replication stress were also observed in nontransformed, proliferative posttetraploid RPE1 cells. Additionally, replication stress promoted higher levels of intercellular genomic heterogeneity and ongoing genomic instability, which could be explained by high rates of mitotic defects, and was alleviated by the supplementation of exogenous nucleosides. Finally, our data found that 4N cancer cells displayed increased migratory and invasive capacity, both in vitro and in primary colorectal tumors, indicating that tetraploidy can promote aggressive cancer cell behavior.—Wangsa, D., Quintanilla, I., Torabi, K., Vila‐Casadesús, M., Ercilla, A., Klus, G., Yuce, Z., Galofré, C., Cuatrecasas, M., Lozano, J. J., Agell, N., Cimini, D., Castells, A., Ried, T., Camps, J. Near‐tetraploid cancer cells show chromosome instability triggered by replication stress and exhibit enhanced invasiveness. FASEB J. 32, 3502–3517 (2018). www.fasebj.org

29 December 2014 in Cancer
Verified
Journal Article
Open access
PDF file
LMLeticia Moreira
Leticia Moreira
JMJenifer Muñoz
Jenifer Muñoz
Miriam CuatrecasasMiriam Cuatrecasas
Miriam Cuatrecasas
IQIsabel Quintanilla
Isabel Quintanilla
MLMaria Liz Leoz
Maria Liz Leoz
FBFrancesc Balaguer
Francesc Balaguer
BACKGROUND: Colorectal cancers (CRCs) that have microsatellite instability (MSI) and mutL homolog 1 (MLH1) immunoloss are observed in 3 clinical scenarios: Lynch syndrome (LS), sporadic MSI CRC, and Lynch‐like syndrome (LLS). v‐Raf murine sarcoma viral oncogene homolog B1 (BRAF) mutational analysis is used to differentiate LS from sporadic MSI CRC. The role of MLH1 promoter methylation status for the differential diagnosis of these clinical forms is not well established. The objectives of this study were: 1) to analyze MLH1 promoter methylation in MLH1‐deficient CRCs by pyrosequencing, and 2) to assess its role in the differential diagnosis of MLH1‐deficient CRCs.METHODS: In total, 165 CRCs were analyzed, including LS (n = 19), MSI BRAF‐mutated CRC (n = 37), MSI BRAF wild‐type CRC (n = 60), and a control group of CRCs without MSI (microsatellite stable [MSS] CRC; n = 49). MLH1 promoter methylation status was analyzed by pyrosequencing, and the ability of different strategies to identify LS was assessed.RESULTS: The average ± standard deviation methylation in LS (9% ± 7%) was significantly lower than that in MSI BRAF‐mutated CRC (42% ± 17%; P < .001) and in MSI BRAF wild‐type CRC (25% ± 19%; P = .002). Somatic MLH1 hypermethylation was detected in 3 patients (15.8%) with LS, in 34 patients (91.9%) with MSI BRAF‐mutated CRC, and in 37 patients (61.7%) with MSI BRAF wild‐type tumors. Patients with MSI BRAF wild‐type, unmethylated tumors (ie, LLS) had a stronger family history of CRC than those who had tumors with MLH1 methylation (P < .05). The sensitivity for ruling out LS was 100% for BRAF analysis, 84.2% for MLH1 methylation analysis, and 84.2% for the combination of both analyses.CONCLUSIONS: Somatic MLH1 promoter methylation occurs in up to 15% of LS CRCs. Somatic BRAF analysis is the most sensitive strategy for ruling out LS. Patients who have CRCs with loss of MLH1 protein expression and neither BRAF mutation nor MLH1 methylation resemble patients with LS. Cancer 2015;121:1395–1404. © 2014 American Cancer Society.

23 May 2018 in Carcinogenesis
Verified
Journal Article
Open access
PDF file
DWDarawalee Wangsa
Darawalee Wangsa
RBRüdiger Braun
Rüdiger Braun
MSMadison Schiefer
Madison Schiefer
EGEdward Michael Gertz
Edward Michael Gertz
DBDaniel Bronder
Daniel Bronder
Thomas RiedThomas Ried
Thomas Ried
Intratumor heterogeneity is a major challenge in cancer treatment. To decipher patterns of chromosomal heterogeneity, we analyzed six colorectal cancer cell lines by multiplex interphase FISH (miFISH). The mismatch-repair-deficient cell lines DLD-1 and HCT116 had the most stable copy numbers, whereas aneuploid cell lines (HT-29, SW480, SW620 and H508) displayed a higher degree of instability. We subsequently assessed the clonal evolution of single cells in two colorectal carcinoma cell lines, SW480 and HT-29, which both have aneuploid karyotypes but different degrees of chromosomal instability. The clonal compositions of the single cell-derived daughter lines, as assessed by miFISH, differed for HT-29 and SW480. Daughters of HT-29 were stable, clonal, with little heterogeneity. Daughters of SW480 were more heterogeneous, with the single cell-derived daughter lines separating into two distinct populations with different ploidy (hyper-diploid and near-triploid), morphology, gene expression and tumorigenicity. To better understand the evolutionary trajectory for the two SW480 populations, we constructed phylogenetic trees which showed ongoing instability in the daughter lines. When analyzing the evolutionary development over time, most single cell-derived daughter lines maintained their major clonal pattern, with the exception of one daughter line that showed a switch involving a loss of APC. Our meticulous analysis of the clonal evolution and composition of these colorectal cancer models shows that all chromosomes are subject to segregation errors, however, specific net genomic imbalances are maintained. Karyotype evolution is driven by the necessity to arrive at and maintain a specific plateau of chromosomal copy numbers as the drivers of carcinogenesis.

4 August 2015 in Carcinogenesis
Verified
Journal Article
Open access
PDF file
KTKeyvan Torabi
Keyvan Torabi
RMRosa Miró
Rosa Miró
Nora Fernandez-JimenezNora Fernandez-Jimenez
Nora Fernandez-Jimenez
IQIsabel Quintanilla
Isabel Quintanilla
LRLaia Ramos
Laia Ramos
IPImmaculada Ponsa
Immaculada Ponsa
Colorectal cancer (CRC) is characterized by specific patterns of copy number alterations (CNAs), which helped with the identification of driver oncogenes and tumor suppressor genes (TSGs). More recently, the usage of single nucleotide polymorphism arrays provided information of copy number neutral loss of heterozygosity, thus suggesting the occurrence of somatic uniparental disomy (UPD) and uniparental polysomy (UPP) events. The aim of this study is to establish an integrative profiling of recurrent UPDs/UPPs and CNAs in sporadic CRC. Our results indicate that regions showing high frequencies of UPD/UPP mostly coincide with regions typically involved in genomic losses. Among them, chromosome arms 3p, 5q, 9q, 10q, 14q, 17p, 17q, 20p, 21q and 22q preferentially showed UPDs/UPPs over genomic losses suggesting that tumor cells must maintain the disomic state of certain genes to favor cellular fitness. A meta-analysis using over 300 samples from The Cancer Genome Atlas confirmed our findings. Several regions affected by recurrent UPDs/UPPs contain well-known TSGs, as well as novel candidates such as ARID1A, DLC1, TCF7L2 and DMBT1. In addition, VCAN, FLT4, SFRP1 and GAS7 were also frequently involved in regions of UPD/UPP and displayed high levels of methylation. Finally, sequencing and fluorescence in situ hybridization analysis of the gene APC underlined that a somatic UPD event might represent the second hit to achieve biallelic inactivation of this TSG in colorectal tumors. In summary, our data define a profile of somatic UPDs/UPPs in sporadic CRC and highlights the importance of these events as a mechanism to achieve the inactivation of TSGs.

1 January 2018 in Journal of Genetics and Genomics
Verified
Journal Article
Closed access
Sebastià Franch-ExpósitoSebastià Franch-Expósito
Sebastià Franch-Expósito
CEClara Esteban-Jurado
Clara Esteban-Jurado
PGPilar Garre
Pilar Garre
IQIsabel Quintanilla
Isabel Quintanilla
SDSaray Duran-Sanchon
Saray Duran-Sanchon
Sergi Castellvi-BelSergi Castellvi-Bel
Sergi Castellvi-Bel

1 July 2020 in American Journal of Surgical Pathology
Verified
Journal Article
Closed access
MJMireya Jimeno
Mireya Jimeno
ADAnna Domingo
Anna Domingo
ISIsabel Salas
Isabel Salas
MSMaría R. Sánchez
María R. Sánchez
CGCarmen González
Carmen González
MPMaria Pellisé
Maria Pellisé
Surveillance colonoscopies focused to detect dysplasia are recommended to prevent colorectal cancer in patients with long-standing colonic inflammatory bowel disease (IBD). To date, histologic diagnosis and gradation of IBD-related dysplasia has been challenged by a high variability among pathologists. We aimed to analyze the observer characteristics that are correlated with concordance deviations in this diagnosis. Eight pathologists evaluated a set of 125 endoscopic biopsy samples with a representative distribution of nondysplastic and dysplastic lesions from long-standing IBD patients. Two rounds of diagnosis were carried out during a period of 18 months. The kappa test was applied to analyze concordance. Pathologists were grouped on the basis of their experience. A subanalysis was performed by eliminating the highly prevalent nondysplastic samples, as well as an analysis after observers' grouping. Overall interobserver agreement was good (kappa = 0.73), with an even higher pairwise value (kappa = 0.86) as well as the intraobserver agreement values (best kappa = 0.85). After eliminating the highly prevalent nondysplastic samples, the interobserver agreement was still moderate to good (best overall kappa= 0.50; best paired kappa = 0.72). Notable differences were seen between the pathologists with a high-volume and low-volume practice (best overall kappa = 0.61 and 0.41, respectively). The agreement in the diagnosis of dysplasia in IBD endoscopic biopsies may have been undervalued over time. This is the first study evaluating pathologists' diagnostic robustness in this field. The results suggest that examining a large volume of samples is the key factor to increase the consistency in the diagnosis and gradation of IBD-related dysplasia.